EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment

Published:2016-02-12 Issue:2 Volume:11 Page:e0149007
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vandewalle Björn,Llibre Josep M.,Parienti Jean-Jacques,Ustianowski Andrew,Camacho Ricardo,Smith Colette,Miners Alec,Ferreira Diana,Félix Jorge

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population;K Bhaskaran;JAMA,2008

2. All-cause mortality in treated HIV-infected adults with CD4 >/ = 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration;C Lewden;International journal of epidemiology,2012

3. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population;AJ Rodger;Aids,2013

4. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial;CJ Cohen;The Lancet,2011

5. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults;CJ Cohen;Aids,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis;Frontiers in Public Health;2022-06-17

2. Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV;Pharmaceuticals;2020-06-11

3. Medication nonadherence, multitablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression;AIDS;2018-06-19

4. Improving community mobilization in HIV treatment management: practical suggestions from patients in Brazil;REV PANAM SALUD PUBL;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3